News archive 2006
Improved medicines thanks to analysis of detoxification enzyme
In a study of the absorption and delivery of (anticancer) medication in the human body, Teun van Herwaarden, a researcher at the NKI-AVL, examined the detoxifying effect of the Cytochrome P450 3A enzymes.
»
Read more
Prestigious Vici-grant awarded to NKI-AVL researcher Daniel Peeper
The grant represents 1.250.000 euro, allowing a research program for 5 years.
»
Read more
Loss of the glue leads to invasive breast cancer
Loss of E-cadherin, a molecule that mediates cell-cell adhesion, leads to an aggressive and metastatic form of breast cancer, i.e. Invasive Lobular Carcinoma (ILC).
»
Read more
Reuven Agami new member The Young Academy
The Young Academy has ten new members: researchers from a variety of disciplines with strong scientific credentials who have all obtained their doctorates within the past ten years.
»
Read more
KWF Fellows
Four of five KWF Fellowships for basic, (pre)clinical or translational research have this year been granted to scientists of the NKI-AVL.
»
Read more
Junk DNA useless?
Junk-DNA, the part of the genetic information that lies between the genes, might not be so useless after all.
»
Read more
CBG Symposium
On October 31 and November 1 2006 the Centre for Biomedical Genetics will organize the symposium Chromosome transactions.
»
Read more
The p53 puzzle
The protein p53 plays an important role in suppressing tumor cells. What’s the trick?
»
Read more
20,000 candidates
Small molecules. Drugs that interfere with signals inside cancer cells and are promising in the search for new effective cancer therapy.
»
Read more
Postdoctoral affairs NKI among leaders
According to scientific magazine Cell
»
Read more
EnzymeX wins Apple Design Award 2006
On August 8th, Alexander Griekspoor and Tom Groothuis won their second Apple Design Award this time for EnzymeX.
»
Read more